Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Weiya Pei, Yingying Zhang, Xueqin Li, Mengsha Luo, Tianbing Chen, Mengying Zhang, Min Zhong, Kun Lv
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Ning Huangfu, Wenyuan Zheng, Zhenyu Xu, Shenghuang Wang, Yong Wang, Jingsong Cheng, Zhenwei Li, Ke'ai Cheng, Shuangshuang Zhang, Xiaomin Chen, Jianhua Zhu
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Wang Zhao, Yangen Xiang, Zhang Zhang, Xueting Liu, Manli Jiang, Binyuan Jiang, Yinghui Song, Jinyue Hu
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Anna Wardowska, Michał Komorniczak, Aneta Skoniecka, Barbara Bułło-Piontecka, Katarzyna A. Lisowska, M.Alicja Dębska-Ślizień, Michał Pikuła
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Cheng Zhang, Yu Gan, Jin-Wei Lv, Ming-Qiang Qin, Wei-Rong Hu, Zhi-Bing Liu, Li Ma, Bing-Dong Song, Jian Li, Wei-Ying Jiang, Jian-Qing Wang, Hua Wang, De-Xiang Xu
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Vida Hashemi, Shohreh Farhadi, Mitra Ghasemi Chaleshtari, Brinton Seashore-Ludlow, Ali Masjedi, Mohammad Hojjat-Farsangi, Afshin Namdar, Amir Ajjoolabady, Hamed Mohammadi, Ghasem Ghalamfarsa, Farhad Jadidi-Niaragh
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Hongyuan Wang, Xiugui Wei, Xian Wei, Xuemei Sun, Xiukun Huang, Yingqin Liang, Wanpeng Xu, Xunshuai Zhu, Xing Lin, Jun Lin
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Xing Zhang, Chao-ran Huang, Sheng Pan, Yong Pang, Ye-shuai Chen, Guo-chun Zha, Kai-jin Guo, Xin Zheng
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Xiguang Feng, Yi Chen, Min Zhang, Miaojie Fang, Cuimei Xiao, Junzhu Chen
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Maria V. Deligiorgi, Gerasimos Siasos, Chrysovalantis Vergadis, Dimitrios T. Trafalis
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Tianyue Wang, Qianlan Zhou, Yunxiao Shang
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Marc Le Vée, Arnaud Bruyère, Elodie Jouan, Olivier Fardel
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Il-Gyu Ko, Jae Joon Hwang, Bok Soon Chang, Sang-Hoon Kim, Jun-Jang Jin, Lakkyong Hwang, Chang-Ju Kim, Cheon Woong Choi
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Xue-Lian Zhao, Liang Yu, Sun-Dong Zhang, Kou Ping, Hai-Yan Ni, Xiang-Yu Qin, Chun-Jian Zhao, Wei Wang, Thomas Efferth, Yu-Jie Fu
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Ingrid Prata Mendonça, Eduardo Duarte-Silva, Adriano José Maia Chaves-Filho, Belmira Lara da Silveira Andrade da Costa, Christina Alves Peixoto
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Guo Xin, Li Xu-yong, Hu Shan, Wu Gang, Chen Zhen, Liu Ji-Jun, Ye Ping, Chen Man-hua
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Shuixian Liu, Xiaoxuan Zhang, Jing Wang
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Nazeer Yasin, Hoti Sugerappa Laxmanappa, Uday M. Muddapur, Jennifer Cheruvathur, S.M. Uday Prakash, Hirekodathakallu Venkataramaiah Thulasiram
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Jingyuan Wan, Ge Kuang, Li Zhang, Rong Jiang, Yongtao Chen, Zhen He, Duyun Ye
Publication date: June 2020Source: International Immunopharmacology, Volume 83Author(s): Saki Nakagawa, Kazuhiro Omori, Masaaki Nakayama, Hiroki Mandai, Satoshi Yamamoto, Hiroya Kobayashi, Hidefumi Sako, Kyosuke Sakaida, Hiroshi Yoshimura, Satoki Ishii, Soichiro Ibaragi, Kimito Hirai, Keisuke Yamashiro, Tadashi Yamamoto, Seiji Suga, Shogo Takashiba
Publication date: July 2020Source: International Immunopharmacology, Volume 84Author(s): Khadijeh Barzaman, Jafar Karami, Zeinab Zarei, Aysooda Hosseinzadeh, Mohammad Hossein Kazemi, Shima Moradi-Kalbolandi, Elahe Safari, Leila Farahmand
Publication date: July 2020Source: International Immunopharmacology, Volume 84Author(s): Abbas Shahi, Shima Afzali, Saeedeh Salehi, Saeed Aslani, Mahdi Mahmoudi, Ahmadreza Jamshidi, Aliakbar Amirzargar
Mark above section as read
Related ArticlesSyringo-Subarachnoid Shunt Placement: A Minimally Invasive Technique Using Fixed Tubular Retractors-Three Case Reports and Literature Review. Int J Spine Surg. 2020 Apr;14(2):133-139 Authors: Srikantha U, Hari A, Lokanath YK, Varma RG Abstract Background: Placement of a syringo-subarachnoid shunt as a surgical management for syringomyelia has been well described in the literature. Good results in terms of clinical and radiological improvement...
Related ArticlesSpinal cerebrospinal fluid leak in the context of pars interarticularis fracture. BMC Neurol. 2020 Apr 29;20(1):162 Authors: Chan TLH, Cowan R, Hindiyeh N, Hashmi S, Lanzman B, Carroll I Abstract BACKGROUND: Spinal cerebrospinal fluid (CSF) leak can lead to intracranial hypotension and is an important differential diagnosis to consider in patients with sudden-onset chronic daily headaches. Pars interarticularis (PI) fracture is a potential...
Related ArticlesA Simplified Approach to Myelomeningocele Defect Repair. Ann Plast Surg. 2020 Apr 27;: Authors: Brown OH, Makar KG, Ulma RM, Buchman SR, Kasten SJ, Muraszko KM, Vercler CJ Abstract BACKGROUND: Repair of the soft tissue defect in myelomeningoceles remains challenging. The literature currently lacks a systematic approach, reporting high rates of complications. We present outcomes from the largest series to date and describe a simplified...
Related ArticlesExpanded Endonasal Approach for Resection of Extradural Infratemporal Fossa Trigeminal Schwannoma: 2-Dimensional Operative Video. Oper Neurosurg (Hagerstown). 2020 Apr 29;: Authors: Asmaro K, Rock J, Craig J Abstract The infratemporal fossa (ITF) is bounded superiorly by the skull base, specifically the greater wing of the sphenoid, which contains foramen ovale. It is bordered posteriorly by the temporal bone, including the petrous portion...
Related ArticlesValue of the Petromeatal Angle in Predicting Outcome of Translabyrinthine Resection of Vestibular Schwannomas. Oper Neurosurg (Hagerstown). 2020 Apr 29;: Authors: Noureldine MHA, Aum D, Piper K, Zavadskiy G, Peto I, Bach K, van Loveren H, Agazzi S Abstract BACKGROUND: Factors associated with extent of tumor resection (EOR) and facial nerve outcomes include tumor size, anterior extension of the tumor, patient age, and surgical approach....
Mark above section as read
Related ArticlesPrevalence of malocclusions and oral dysfunctions in children with persistent sleep-disordered breathing after adenotonsillectomy in the long term. J Clin Sleep Med. 2020 May 01;: Authors: Cohen-Levy J, Quintal MC, Rompré P, Almeida F, Huynh N Abstract STUDY OBJECTIVES: To evaluate the prevalence of craniofacial/orthodontic abnormalities and oral dysfunctions in a population of children with persistent sleep-disordered breathing (SDB)...
New Diagnosis of Obstructive Sleep Apnea Following Anterior Cervical Discectomy Complicated by Rheumatoid Arthritis: A Case Report. Cureus. 2020 Mar 27;12(3):e7439 Authors: Wasey W, Festic E, Sapra A, Rafi T, Bhandari P Abstract Obstructive sleep apnea (OSA) is the most common variant of sleep-disordered breathing that often goes undiagnosed. OSA is characterized mainly by anatomical obstruction or partial collapse of upper airways during sleep. The...
Related ArticlesDifferent barbed pharyngoplasty techniques for retropalatal collapse in obstructive sleep apnea patients: a systematic review. Sleep Breath. 2020 Apr 29;: Authors: Moffa A, Rinaldi V, Mantovani M, Pierri M, Fiore V, Costantino A, Pignataro L, Baptista P, Cassano M, Casale M Abstract BACKGROUND: The use of barbed sutures (BS) for the treatment of retropalatal collapse and vibration in patients suffering from snoring and obstructive sleep...
Related ArticlesVarious Motor and Non-Motor Symptoms in Early Multiple System Atrophy. Neurodegener Dis. 2020 Apr 29;:1-6 Authors: Jung YJ, Kim HJ, Yoo D, Choi JH, Im JH, Yang HJ, Jeon B Abstract BACKGROUND: Multiple system atrophy (MSA) patients pre-sent a variety of symptoms other than autonomic dysfunctions, parkinsonism, and cerebellar ataxia. The aim of this study was to evaluate the frequency of various motor and non-motor symptoms including so-called...
Related ArticlesA New Feature with the Potential to Detect the Severity of Obstructive Sleep Apnoea via Snoring Sound Analysis. Int J Environ Res Public Health. 2020 Apr 24;17(8): Authors: Hayashi S, Tamaoka M, Tateishi T, Murota Y, Handa I, Miyazaki Y Abstract The severity of obstructive sleep apnoea (OSA) is diagnosed with polysomnography (PSG), during which patients are monitored by over 20 physiological sensors overnight. These sensors often bother...
Mark above section as read
Mark above section as read
Related ArticlesTissue cross-reactivity studies of CPGJ701 in humans, cynomolgus monkeys and Sprague-Dawley rats and correlation analysis with in vivo toxicity. Ann Transl Med. 2020 Mar;8(6):325 Authors: Qu Z, Lyu J, Liu Y, Wang X, Lin Z, Yang Y, Zhang D, Geng X, Li B Abstract Background: CPGJ701 is a recombinant humanized anti-human epidermal growth factor receptor-2 (HER2) monoclonal antibody-derivative of the cytotoxic agent maytansine (DM1) conjugate...
CDK4/6 inhibition in HER2-positive breast cancer. Lancet Oncol. 2020 Apr 27;: Authors: Battisti NML, Ring A PMID: 32353343 [PubMed - as supplied by publisher]
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial. Lancet Oncol. 2020 Apr 27;: Authors: Tolaney SM, Wardley AM, Zambelli S, Hilton JF, Troso-Sandoval TA, Ricci F, Im SA, Kim SB, Johnston SR, Chan A, Goel S, Catron K, Chapman SC, Price GL, Yang Z, Gainford MC, André F Abstract...
Screening of a Novel Upregulated lncRNA, A2M-AS1, That Promotes Invasion and Migration and Signifies Poor Prognosis in Breast Cancer. Biomed Res Int. 2020;2020:9747826 Authors: Fang K, Caixia H, Xiufen Z, Zijian G, Li L Abstract Understanding of prognostic factors and therapeutic targets for breast cancer is imperative for guidance of patient care. We studied 1203 tumour samples from the Gene Expression Omnibus (GEO) to evaluate potential genes related...
Related ArticlesCan pathology diagnostic services for cancer be stratified and serve global health? Cancer. 2020 May 15;126 Suppl 10:2431-2438 Authors: Anglade F, Milner DA, Brock JE Abstract BACKGROUND: Before initiating cancer therapy, a diagnostic tumor tissue sample evaluated within a pathology laboratory by a pathologist is essential to confirm the malignancy type and provide key prognostic factors that direct the treatment offered. METHODS:...
Related ArticlesSystemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival. J Neurooncol. 2020 Apr 29;: Authors: Chen TW, Jan IS, Chang DY, Lin CH, Chen IC, Chen HM, Cheng AL, Lu YS Abstract INTRODUCTION: Metastatic breast cancer (MBC) with leptomeningeal metastases (LM) has dismal survival. We aim to determine if modern systemic therapy, especially...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου